Immunity in atherosclerosis: focusing on T and B cells

AV Poznyak, EE Bezsonov, TV Popkova… - International Journal of …, 2021 - mdpi.com
Atherosclerosis is the major cause of the development of cardiovascular disease, which, in
turn, is one of the leading causes of mortality worldwide. From the point of view of …

Cryo-EM structure of the human IgM B cell receptor

Q Su, M Chen, Y Shi, X Zhang, G Huang, B Huang… - Science, 2022 - science.org
The B cell receptor (BCR) initiates immune responses through antigen recognition. We
report a 3.3-angstrom cryo–electron microscopy structure of human immunoglobulin M (IgM) …

Regulation of B-cell receptor signaling and its therapeutic relevance in aggressive B-cell lymphomas

N Profitós-Pelejà, JC Santos, A Marín-Niebla, G Roué… - Cancers, 2022 - mdpi.com
Simple Summary Dysregulated B-cell receptor (BCR) signaling is considered a potent
contributor to tumor survival in different subtypes of B-cell non-Hodgkin lymphomas (B …

NFKBIE mutations are selected by the tumor microenvironment and contribute to immune escape in chronic lymphocytic leukemia

A Bonato, S Chakraborty, R Bomben, G Canarutto… - Leukemia, 2024 - nature.com
Loss-of-function mutations in NFKBIE, which encodes for the NF-κB inhibitor IκBε, are
frequent in chronic lymphocytic leukemia (CLL) and certain other B-cell malignancies and …

If small molecules immunotherapy comes, can the prime be far behind?

J Zhang, Y Zhang, B Qu, H Yang, S Hu… - European Journal of …, 2021 - Elsevier
Anti-cancer immunotherapy, which includes cellular immunotherapy, immune checkpoint
inhibitors and cancer vaccines, has transformed the treatment strategies of several …

A loss-of-adhesion CRISPR-Cas9 screening platform to identify cell adhesion-regulatory proteins and signaling pathways

MFM de Rooij, YJ Thus, N Swier… - Nature …, 2022 - nature.com
The clinical introduction of the Bruton's tyrosine kinase (BTK) inhibitor ibrutinib, which targets
B-cell antigen-receptor (BCR)-controlled integrin-mediated retention of malignant B cells in …

[HTML][HTML] The inositol 5-phosphatase INPP5B regulates B cell receptor clustering and signaling

A Droubi, C Wallis, KE Anderson, S Rahman… - Journal of Cell …, 2022 - rupress.org
Upon antigen binding, the B cell receptor (BCR) undergoes clustering to form a signalosome
that propagates downstream signaling required for normal B cell development and …

Current Status of Novel Agents for the Treatment of B Cell Malignancies: What's Coming Next?

M Tannoury, D Garnier, SA Susin, B Bauvois - Cancers, 2022 - mdpi.com
Simple Summary Since the identification of a large variety of biomarkers in B cell
malignancies as being driving factors for tumor progression and patient prognosis, their …

[HTML][HTML] Does IFITM3 link inflammation to tumorigenesis?

J Lee - Bmb Reports, 2022 - ncbi.nlm.nih.gov
Uncontrolled chronic inflammation, in most cases due to excessive cytokine signaling
through their receptors, is known to contribute to the development of tumorigenesis …

[HTML][HTML] A role for Hes1 in constraining germinal center B cell formation

X Shao, X Liu, H Qi - Cell Insight, 2023 - Elsevier
Germinal center is a transient lymphoid tissue structure in which B cells undergo affinity
maturation and differentiate into memory B cells and plasma cells. GC formation depends on …